Variation in the gene for the beta-1 adrenergic receptor increases the risk that a patient will have an abnormal heart rhythm after cardiac surgery.
Targeting the production of molecules that promote tumor blood vessel development offers a new path for treating lung cancer.
The antioxidant vitamin E prevented the buildup of toxic products in a model of a rare genetic disorder, suggesting new strategies for therapeutic development.
It might be possible to generate a “metabolically healthy” state of obesity by targeting signaling pathways that improve insulin sensitivity.
A new computational model of the interactions between vocal folds and the air around them could aid in designing new treatments for voice disorders.
According to annual figures available through the National Institutes of Health (NIH), Vanderbilt University School of Medicine (VUSM) is now ranked ninth in the nation among U.S. medical schools in total grant support provided through the nation’s medical research agency.